Rifaximin
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Antibiotics & Anti-Infectives treatment.
🧴 Clinical Application
Swallow whole with a glass of water, with or without food. For hepatic encephalopathy, take consistently twice daily as long-term maintenance therapy. For traveler's diarrhea or IBS-D, complete the prescribed 3-day or 14-day course.
⚠️ Side Effects
Common: Flatulence, abdominal pain, nausea, dizziness, headache, defecation urgency. Rare/Severe: Clostridioides difficile-associated diarrhea (rare but possible), severe hypersensitivity reactions, and angioedema.
🛡️ Safety Warnings
Not effective in diarrheal illnesses caused by invasive pathogens (Campylobacter, Salmonella, Shigella) or systemic bacterial infections accompanied by high fever or bloody stools. Caution in severe hepatic impairment (Child-Pugh C) due to slightly increased systemic exposure.
Jan Aushadhi Products containing Rifaximin
Found 3 generic formulation(s) containing this active ingredient.
Rifaximin Tablets 400 mg
Rifaximin is a non-systemic, gut-selective rifamycin-class antibacterial agent. It acts by binding to the beta-subunit of bacterial DNA-dependent RNA polymerase, blocking bacterial RNA transcription. Oral bioavailability is less than 0.4%, ensuring minimal systemic absorption and concentrating therapeutic power within the intestinal lumen without disturbing extraintestinal flora. Indicated for traveler's diarrhea (caused by non-invasive E. coli), reduction in risk of overt hepatic encephalopathy recurrence, and irritable bowel syndrome with diarrhea (IBS-D).
Rifaximin Tablets 200 mg
Rifaximin is a non-systemic, gut-selective rifamycin-class antibacterial agent. It acts by binding to the beta-subunit of bacterial DNA-dependent RNA polymerase, blocking bacterial RNA transcription. Oral bioavailability is less than 0.4%, ensuring minimal systemic absorption and concentrating therapeutic power within the intestinal lumen without disturbing extraintestinal flora. Indicated for traveler's diarrhea (caused by non-invasive E. coli), reduction in risk of overt hepatic encephalopathy recurrence, and irritable bowel syndrome with diarrhea (IBS-D).
Rifaximin Tablets 550 mg
Rifaximin is a non-systemic, gut-selective rifamycin-class antibacterial agent. It acts by binding to the beta-subunit of bacterial DNA-dependent RNA polymerase, blocking bacterial RNA transcription. Oral bioavailability is less than 0.4%, ensuring minimal systemic absorption and concentrating therapeutic power within the intestinal lumen without disturbing extraintestinal flora. Indicated for traveler's diarrhea (caused by non-invasive E. coli), reduction in risk of overt hepatic encephalopathy recurrence, and irritable bowel syndrome with diarrhea (IBS-D).
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Rifaximin.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Rifaximin Tablets 400 mg | 10's | ₹134.06 | RIFAGUT, RCIFAX, RIFCURE, RIFASTOP, REXIGUT | ₹356.96 | 62% Save |
| Rifaximin Tablets 200 mg | 10's | ₹65.63 | RIFAGUT, REXIGUT, RCIFAX, LOMOTIL, RIFCURE | ₹218.73 | 70% Save |
| Rifaximin Tablets 550 mg | 10's | ₹159.38 | RIFAGUT, REXIGUT, RCIFAX, RIFCURE, RIFASMART | ₹445.25 | 64% Save |
Frequently Asked Questions (FAQ)
Get answers to common queries about Rifaximin generics.